top of page
Screen Shot 2021-12-01 at 9.56.39 AM.png

Contesting the Frame: Psychedelics, Psychiatry, and the Edges of Clinical Science

Franklin King, MD

COURSE DATES:

COURSE LENGTH:

SCHEDULE:

FORMAT(S):

Week 2: July 9-10, 2026

Thursday-Friday

9:00 a.m. - 1:30 p.m. EDT

30-minute break daily

2 Half-Days (8-Hour Course)

In-Person, Live-Online

This course is no longer available.

QUANTITY:

IN-PERSON COURSE SOLD OUT!

Price:

$0.00

ADD TO CART
JOIN THE IN-PERSON WAITLIST HERE!

COURSE FORMAT & TUITION:

_

Error text

Sold out

Course Description

Although psychedelics are on the verge of becoming “mainstream”, significant disagreements exist over how to best study and use them, for what purposes, and in what settings.  Research over the last twenty years has led to an enhanced understanding of how psychedelics might be used to treat mental health conditions, while other areas of research are pushing the boundaries of our understandings of consciousness, exploring new frontiers in spirituality and religion, and driving political and legislative change.


The purpose of this course is to review the history and clinical science of psychedelics based on contemporary understandings, followed by a deeper dive into more outside-the-box applications beyond individual therapy sessions using psychedelics for psychiatric conditions.  This will include discussions of integration of meditation and psychedelics, clinical uses beyond psychiatry including functional medical disorder, integrative medicine, and psychosomatic conditions.  The limits of the current medical model and randomized controlled trials in adequately evaluating and studying psychedelics will be discussed, with an orientation toward critical thinking in understanding why some of the current biases and issues within psychedelic research and the public narrative exist, and the challenges that psychedelics will likely face as they become “mainstreamed”. The format will consist of didactic sessions and small group discussions. Specific readings may be assigned and participants will be asked to share and reflect. Following this course, participants should have a comprehensive understanding of where psychedelics might be headed as societal-level psychedelic literacy develops over the coming years.

Course Agenda

Course Objectives

About the Instructor

Franklin King, MD

Speaker Disclosures:

Financial: Franklin King has no financial relationships with ineligible organizations. He receives a speaking honorarium from MAK Continuing Education, LLC, Cape Cod Institute.

Non-financial: Franklin King has no non-financial relationships with ineligible organizations.

Franklin King, MD, is a psychiatrist at the Massachusetts General Hospital and an Instructor in Psychiatry at Harvard Medical School. He is a graduate of the University of Massachusetts Medical School, after which he completed residency in adult psychiatry at the MGH/McLean program. He has completed post-residency fellowships, both at MGH, in Consult Liaison Psychiatry and a research fellowship at the Cardiac Psychiatry Research Center. Dr. King has practiced in a variety of clinical roles at MGH including the Neuropsychiatry Clinic, the Adult Outpatient Clinic, the Center for Anxiety and Traumatic Stress Disorders Clinical and Research Program, the Avery Weissman Psychiatric Consult Service, and the Acute Psychiatry Service. His areas of research include optimization of therapy paradigms within psychedelic research as well as the use of psychedelic-assisted therapies in disorders at the mind-body interface.  Dr. King is currently the Principal Investigator in a pilot study exploring the feasibility of psilocybin-assisted therapy for irritable bowel syndrome, Co-PI of a collaborative study examining the use of psychedelic coaches in the MGH Ketamine Clinic, and is the study psychiatrist for a neuroimaging study examining the effects of MDMA-assisted therapy for fibromyalgia.  He is also co-developing the Harvard-wide Interdisciplinary Program in Psychedelics with colleagues at BWH and BIDMC, a program that provides education and training in psychedelic-assisted therapies for clinicians across the HMS community.

Franklin King, MD
Franklin King, MD
Franklin King, MD

Hear more from 

Franklin King, MD

00:00 / 01:04

What Alumni are Saying...

"This course was phenomenal and has left me with so much to think about. Dr. King is incredibly knowledgeable with a depth and breadth of knowledge that is impressive. I appreciate greatly his thorough understanding of not only the treatment aspects of psychedelics, but his thorough and in-depth exploration of the context in which psychedelics exist." - 2024 Participant

"Dr. King was a wonderful presenter. He has great breadth of knowledge of the field from his role as a clinical investigator and can speak to what is known and not known about the use of psychedelics and PAT in the treatment of clinical conditions in a remarkably balanced way. Equally impressive is his obvious respect for and humility about how these agents are used in non-Western healing traditions, and his willingness to use this to inform "best practices" for Western practitioners." - 2024 Participant

"Franklin was very professional, knowledgeable, and presented very well." - 2024 Participant

Franklin King, MD
Questions?
IMG_0022.HEIC

QUESTIONS?

CONTACT US for more info about this course

Course Format

Thanks for submitting! We'll be in touch soon.

bottom of page